Company intelligence / Profile preview

PL Capital

Konstantynów Łódzki, Poland

Ownership: Private
Development stage: Other

Overview

PL Capital is a Polish investment and holding company that maintains a significant presence in the life sciences and biotechnology sectors through its strategic ownership stakes. The company is most notably recognized as a major shareholder in Mabion, a leading European biotech company focused on the development and manufacturing of therapeutic proteins and biosimilars. PL Capital operates as a vehicle for capital management and strategic oversight, supporting the growth of innovative healthcare enterprises in Central and Eastern Europe. Its business model centers on providing long-term financial stability and corporate governance to its portfolio companies within the pharmaceutical and medical technology industries.

Industry: Investors

Beyond the preview

Go deeper on PL Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PL Capital.

Explore the full profile